Literature DB >> 15567291

Improvement of warfarin biopharmaceutics by conjugation with poly(ethylene glycol).

Marina Zacchigna1, Gabriella Di Luca, Francesca Cateni, Venerando Maurich.   

Abstract

One of the most used and useful polymers, poly(ethylene glycol) (PEG) was used as a carrier for warfarin. The drug-polymer conjugate was freely water soluble at room temperature. The hydrolytic stability of the PEG-warfarin was investigated at physiological pH and confirmed the stability of the conjugate. In vivo release studies demonstrated a good release of parent drug, without the initial high plasma level of warfarin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15567291     DOI: 10.1016/j.ejps.2004.09.001

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  2 in total

1.  In Vitro and In Vivo Study of Poly(ethylene glycol) Conjugated Ibuprofen to Extend the Duration of Action.

Authors:  Anjali Nayak; Anurekha Jain
Journal:  Sci Pharm       Date:  2011-03-20

Review 2.  Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?

Authors:  Marek Saracyn; Dorota Brodowska-Kania; Stanisław Niemczyk
Journal:  ScientificWorldJournal       Date:  2013-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.